{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T05:41:57Z","timestamp":1695879717641},"reference-count":7,"publisher":"Wiley","issue":"s1","license":[{"start":{"date-parts":[[2009,4,24]],"date-time":"2009-04-24T00:00:00Z","timestamp":1240531200000},"content-version":"vor","delay-in-days":4406,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mycoses"],"published-print":{"date-parts":[[1997,4]]},"abstract":"<jats:p><jats:bold>Zusammenfassung. <\/jats:bold> Zwei Patientenkollektive (jewells n=50) mit Bestrahlungen im oropharyngealen Bereich bei Plattenepithelkarzinomen der Kopf\u2010Hals\u2010Region mit und ohne prophylaktischer Fluconazolgabe von 100 mg\/die wurden auf das Vorkommen von Mundsoor und daraus resultierenden Bestrahlungspausen ausgewertet. Beim Vergleich traten in dem Kollektiv ohne Fluconazolgabe bei 40% (n = 20) Mundsoor auf, der in 14% der F\u00e4lle (n = 7) eine Bestrahlungspause erforderlich machte. Bei Patienten, die prophylaktisch Fluconazol erhielten, wurde klinisch kern Mundsoor diagnostiziert, es traten keine soorbedingten Bestrahlungspausen auf. Bei 15 weiteren Patienten mit Fluconazolprophylaxe liegen kulturelle Untersuchungsbefunde auf <jats:italic>Candida<\/jats:italic> (Mundsp\u00fclwasser und Stuhl) zu Beginn und zum Ende der Strahlentherapie vor. Unter Fluconazol wird <jats:italic>Candida albicans<\/jats:italic> am Ende der Radiotherapie weniger h\u00e4ufig isoliert, auffallend sind vermehrte Isolierungen von <jats:italic>C. glabrata<\/jats:italic> und <jats:italic>C. krusei.<\/jats:italic> Unter Radiatio von Patienten mit Kopf\u2010Hals\u2010Tumoren sind aus unserer Sicht prophylaktische Fluconazolgaben (100 mg\/die) zur Vermeidung soorbedingter Bestrahlungspausen sinnvoll und effektiv.<\/jats:p><jats:p><jats:bold>Summary. <\/jats:bold> The aim of the present study was to investigate the incidence of <jats:italic>Candida<\/jats:italic> stomatitis and resulting interruptions in radiation therapy in 50 patients suffering from squamous cell carcinomas of head and neck region receiving fluconazole (100 mg\/d) in comparison to a historical control group without specific prophylaxis. 20 of the control patients (40%) demonstrated <jats:italic>Candida<\/jats:italic> stomatitis with 7 of them (14%) requiring interruptions of radiation therapy. In contrast, none of the patients with fluconazole had evidence of <jats:italic>Candida<\/jats:italic> stomatitis and subsequent interruption of anticancer therapy. Laboratory monitoring for the presence of <jats:italic>Candida<\/jats:italic> species was performed in 15 other patients before and after therapy with fluconazole. <jats:italic>Candida albicans<\/jats:italic> was identified less frequently after therapy when compared to the pretreatment status. However. <jats:italic>C. glabrata<\/jats:italic> and <jats:italic>C. krusei<\/jats:italic> were isolated in some of the patients probably due to decreased drug susceptibility of these species. The results demonstrate the clinical usefulness of prophylactic fluconazole applications in patients suffering from head and neck tumors with the aim to reduce <jats:italic>Candida<\/jats:italic> stomatitis and resulting interruptions in radiation therapy.<\/jats:p>","DOI":"10.1111\/j.1439-0507.1997.tb00542.x","type":"journal-article","created":{"date-parts":[[2009,4,24]],"date-time":"2009-04-24T16:43:25Z","timestamp":1240591405000},"page":"53-55","source":"Crossref","is-referenced-by-count":6,"title":["Einsatz von Fluconazol zur antimykotischen Prophylaxe bei Bestrahlungen von Patienten mit Kopf\u2010Hals\u2010Tumoren"],"prefix":"10.1111","volume":"40","author":[{"given":"R.","family":"M\u00fccke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ursula","family":"Kaben","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Libera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Knauerhase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.\u2010G.","family":"Ziegler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Hamann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Strietzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,4,24]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001622-199208000-00008"},{"key":"e_1_2_1_3_2","first-page":"152","article-title":"Oral problems and the dentist's role in the management of paediatric oncology patients","volume":"19","author":"Fayle S.\u2010A.","year":"1992","journal-title":"Dental Update"},{"issue":"12","key":"e_1_2_1_4_2","first-page":"11","article-title":"Prevention and management of oral mucositis induced by antineoplastic therapy","volume":"5","author":"Sonis S.","year":"1991","journal-title":"Oncology"},{"issue":"1","key":"e_1_2_1_5_2","first-page":"4","article-title":"CHART bei H\u2010 & N\u2010Tumoren \u2013 die Gr\u00f6\u00dfe bestimmt die Behandlungszeit","volume":"172","author":"Herrmann Th.","year":"1996","journal-title":"Strahlentherapie und Onkologie"},{"issue":"1","key":"e_1_2_1_6_2","first-page":"6","article-title":"Radio\u2010Chemotherapie von Kopf\u2010Hals\u2010Tumoren: Eine Analyse randomisierter Studien","volume":"172","author":"Wendt Th.\u2010G.","year":"1996","journal-title":"Strahlentherapie und Onkologie"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1006\/clin.1993.1036"},{"key":"e_1_2_1_8_2","first-page":"546","article-title":"Management of fungal infection in neutropenic patients with fluconazole","volume":"33","author":"Brammer K.\u2010W.","year":"1990","journal-title":"H\u00e4matol.-Bluttransfus."}],"container-title":["Mycoses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1439-0507.1997.tb00542.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1439-0507.1997.tb00542.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T02:15:37Z","timestamp":1695780937000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1439-0507.1997.tb00542.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,4]]},"references-count":7,"journal-issue":{"issue":"s1","published-print":{"date-parts":[[1997,4]]}},"alternative-id":["10.1111\/j.1439-0507.1997.tb00542.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1439-0507.1997.tb00542.x","archive":["Portico"],"relation":{},"ISSN":["0933-7407","1439-0507"],"issn-type":[{"value":"0933-7407","type":"print"},{"value":"1439-0507","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,4]]}}}